# kaal:claim:2317580-034

**Claim.** Abbott Labs set the stage for the Pfizer holding: although Abbott's Voluntary Compliance Plan was not a CIA, the Seventh Circuit used it as evidence that the directors knew of and should have stopped noncompliant activities.

**Type.** empirical  **Support.** evidenced

**Holds when.**

- In re Abbott Laboratories Derivative Shareholders Litigation
- a six year history of documented FDA noncompliance

**Source quote.**

> Although the Voluntary Compliance Plan was not a CIA, the Seventh Circuit used it as evidence that the directors knew of and should have stopped noncompliant activities.

**From.** Wulf A. Kaal, Elizabeth R. Malay, *The Role of Corporate Integrity Agreements in the Expansion of Fiduciary Duties* (2013), IV.2 Delineating the Role of CIAs in Fiduciary Duties, page 18

**Cite as.** Wulf A. Kaal, Elizabeth R. Malay, The Role of Corporate Integrity Agreements in the Expansion of Fiduciary Duties (2013). SSRN: https://ssrn.com/abstract=2317580

**Verify.** sha256 of source PDF `50973e1e820aef47a4e7ffdbdcb513d03f1845643fcf4fa5910e9528a0b7dac2` at https://raw.githubusercontent.com/wulfkaal/Academic-Papers/main/papers/pdf/Kaal%20and%20Malay%20-%202013%20-%20The%20Role%20of%20Corporate%20Integrity%20Agreements%20in%20the%20Expansion%20of%20Fiduciary%20Duties.pdf

**Topics.** compliance, citation-and-knowledge

**Keywords.** abbott-labs, voluntary-compliance-plan, knowledge-inference, fda

**Canonical form.** This markdown file is the canonical hashed representation of the claim. Its sha256 is the content hash used for attestation.